NewAmsterdam Pharma Company N.V. (NAMSW)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMSW · CIK 1936258

4 · Oct 2, 2026 · Director, Chief Scientific Officer Kastelein Johannes Jacob Pieter sold 50.25K shares at $25.03/share ($1.3M); exercised options for 100.49K shares

Director, Chief Scientific Officer Kastelein Johannes Jacob Pieter sold 50.25K shares at $25.03/share ($1.3M); exercised options for 100.49K shares

Filed: Oct 2, 2026
Accession: 0001193125-26-412431
Filer: NewAmsterdam Pharma Co N.V.

View on SEC.gov All SEC filings

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.